Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Treatment with chemotherapy or radiation is not invariably cytotoxic to all tumor cells. Some of the cells that survive treatment recover and resume proliferation, whereas others undergo permanent growth arrest. To understand the nature of treatment-induced terminal growth arrest, colon carcinoma cells were exposed to doxorubicin, and surviving cells were separated into proliferating and growth-arrested populations. Only growth-arrested cells displayed phenotypic markers of cell senescence and failed to form colonies. Gene expression was compared between senescent and proliferating fractions of drug-treated cells by using cDNA microarray hybridization and reverse transcription–PCR. Drug-induced senescence was associated with inhibition of genes involved in cell proliferation and with coinduction of multiple intracellular and secreted growth inhibitors. Several tumor suppressors and other genes that are down-regulated in carcinogenesis were up-regulated in senescent tumor cells. Induction of most growth inhibitors was delayed but not abolished in cells with homozygous knockout of p53, in agreement with only limited p53 dependence of drug-induced terminal growth arrest. On the other hand, senescent cells overexpressed secreted proteins with antiapoptotic, mitogenic, and angiogenic activities, suggesting that drug-induced senescence is associated with paracrine tumor-promoting effects. About one-third of the genes up-regulated in senescent cells and almost all of the down-regulated genes showed decreased or delayed changes in p21 Waf1/Cip1/Sdi1 -deficient cells, indicating that p21 is a major mediator of the effects of p53 on gene expression. Elucidation of molecular changes in tumor cells that undergo drug-induced senescence suggests potential strategies for diagnostics and therapeutic modulation of this antiproliferative response in cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many types of cytotoxic chemotherapies are severe DNA-damaging agents that can induce senescence in both tumor cells and surrounding normal cells (31–34).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [31]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Senescent cells acquire many changes in gene expression, mostly documented as altered mRNA abundance, including increased expression of secreted proteins [ 33 – 41 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Pearson, M., Carbone, R., Sebastiani, C., Cioce, M., Fagioli, M., Saito, S., Higashimoto, Y., Appella, E., Minucci, S., Pandolfi, P. P., et al. (2000) · Nature · doi:10.1038/35018127 · Cited by 847
Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., & Wilson, L. (1996) · PubMed · Cited by 770
Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., et al. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7160 · Cited by 714
Self-citationMitotic Misregulation and Human Aging
Ly, D. H., Lockhart, D. J., Lerner, R. A., & Schultz, P. G. (2000) · Science · doi:10.1126/science.287.5462.2486 · Cited by 599
Mutations truncating the EP300 acetylase in human cancers
Gayther, S. A., Batley, S. J., Linger, L., Bannister, A., Thorpe, K., Chin, S.-F., Daigo, Y., Russell, P., Wilson, A., Sowter, H. M., et al. (2000) · Nature Genetics · doi:10.1038/73536 · Cited by 587
Research works printed but not linked: 6
- B D Chang, E V Broude, M Dokmanovic, H Zhu, A Ruth, Y Xuan, E S Kandel, E Lausch, K Christov, I B Roninson Cancer Res 59, 3761–3767 (1999).
- J Campisi In Vivo (Athens, Greece) 14, 183–188 (2000).
- M A Jordan, K Wendell, S Gardiner, W B Derry, H Copp, L Wilson Cancer Res 56, 816–825 (1996).
- S K Myohanen, S B Baylin, J G Herman Cancer Res 58, 591–593 (1998).
- T Waldman, K W Kinzler, B Vogelstein Cancer Res 55, 5187–5190 (1995).
- Dotto, G. P. (2000) Biochim. Biophys. Acta 1471, M43-M56.
Cited by
Items 201–300 of 365
An overview of CDK3 in cancer: clinical significance and pharmacological implications
Teo, T., Kasirzadeh, S., Albrecht, H., Sykes, M. J., Yang, Y., & Wang, S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106249 · Cited by 23
Ewald, J. A., & Jarrard, D. F. (2012) · Translational Oncology · doi:10.1593/tlo.12181 · Cited by 22
Michienzi, S., Bucci, B., Falzacappa, C. V., Patriarca, V., Stigliano, A., Panacchia, L., Brunetti, E., Toscano, V., & Misiti, S. (2007) · Journal of Endocrinology · doi:10.1677/joe.1.07065 · Cited by 22
Park, S.-J., Wu, C.-H., & Safa, A. R. (2004) · PubMed · Cited by 22
Parissenti, A. M., Hembruff, S. L., Villeneuve, D. J., Veitch, Z. W. N., Guo, B., & Eng, J. (2007) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e3280262427 · Cited by 22
Dungan, C. M., Wells, J. M., & Murach, K. A. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00553.2022 · Cited by 21
Nuclear localization of p65 reverses therapy-induced senescence
Salunkhe, S. J., Mishra, S. V., Nair, J., Shah, S. G., Gardi, N., Thorat, R. A., Sarkar, D., Rajendra, J., Kaur, E., & Dutt, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.253203 · Cited by 21
Simulation model of doxorubicin activity in islets of human breast cancer cells
Lankelma, J., Luque, R. F., Dekker, H., & Pinedo, H. M. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00139-9 · Cited by 21
Veraldi, K. L., & Feghali-Bostwick, C. A. (2012) · The Open Rheumatology Journal · doi:10.2174/1874312901206010140 · Cited by 21
Toillon, R., Magné, N., Laïos, I., Castadot, P., Kinnaert, E., Houtte, P. V., Desmedt, C., Leclercq, G., & Lacroix, M. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.040 · Cited by 21
Advances in the molecular regulation mechanism of tumor dormancy and its therapeutic strategy
Wang, Y., Wang, L., Wei, Y., Wei, C., Yang, H., Chen, Q., Zhang, R., & Shen, H. (2024) · Discover Oncology · doi:10.1007/s12672-024-01049-2 · Cited by 21
Diaz-Montero, C. M., & McIntyre, B. W. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-39 · Cited by 21
Transcriptional changes facilitate mitotic catastrophe in tumour cells that contain functional p53
Mansilla, S., Priebe, W., & Portugal, J. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.04.035 · Cited by 21
The Yin-Yang of DNA Damage Response: Roles in Tumorigenesis and Cellular Senescence
Li, X., Xu, H., Chong-an, X., Lin, M., Song, X., Yi, F., Feng, Y., Coughlan, K. A., Cho, W., Kim, S. W., et al. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14022431 · Cited by 20
Kang, H. T., Lee, C. J., Seo, E. J., Bahn, Y. J., Kim, H. J., & Hwang, E. S. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.10.001 · Cited by 20
Kim, T. R., Lee, H. M., Lee, S. Y., Kim, E. J., Kim, K. C., Paik, S. G., Cho, E., & Kim, I. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.018 · Cited by 20
Epigenetic and functional analysis of IGFBP3 and IGFBPrP1 in cellular immortalization
Fridman, A. L., Rosati, R., Li, Q., & Tainsky, M. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.019 · Cited by 19
Treatment-induced cell cycle kinetics dictate tumor response to chemotherapy
Hallett, R. M., Huang, C. Y., Motazedian, A., der Mauer, S. A., Pond, G. R., Hassell, J. A., Nordon, R. E., & Draper, J. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3140 · Cited by 19
Clinical Implications of Cellular Senescence on Wound Healing
Resnik, S. G., Egger, A. N., Abujamra, B. A., & Jozic, I. (2020) · Current Dermatology Reports · doi:10.1007/s13671-020-00320-3 · Cited by 18
Weis, K. E., & Raetzman, L. T. (2019) · Toxicology · doi:10.1016/j.tox.2019.152306 · Cited by 18
Ballot, C., Jendoubi, M., Kluza, J., Jonneaux, A., Laine, W., Formstecher, P., Bailly, C., & Marchetti, P. (2011) · APOPTOSIS · doi:10.1007/s10495-011-0681-2 · Cited by 18
Genetic inhibition of telomerase results in sensitization and recovery of breast tumor cells
Poynter, K. R., Sachs, P. C., Bright, A. T., Breed, M. S., Nguyen, B. N., Elmore, L. W., & Holt, S. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0849 · Cited by 18
Unveiling the impact of CDK8 on tumor progression: mechanisms and therapeutic strategies
Yin, X., He, Z., Chen, K., Ouyang, K., Yang, C., Li, J., Tang, H., & Cai, M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1386929 · Cited by 18
Bendamustine, but not fludarabine, exhibits a low stem cell toxicity in vitro
Schmidt‐Hieber, M., Busse, A., Reufi, B., Knauf, W. U., Thiel, E., & Blau, I. W. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0453-8 · Cited by 18
Nickless, A., Cheruiyot, A., Flanagan, K. C., Piwnica-Worms, D. R., Stewart, S. A., & You, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.787846 · Cited by 17
Personalized Medicine: Regulation of Genes in Human Skin Ageing
Khorsandi, D., Moghanian, A., & Nazari, R. (2016) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000245 · Cited by 17
Tenovin-1 Induces Senescence and Decreases Wound-Healing Activity in Cultured Rat Primary Astrocytes
Bang, M., Ryu, O., Kim, D. G., Mabunga, D. F., Cho, K. S., Kim, Y., Han, S.-H., Kwon, K. J., & Shin, C. Y. (2019) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.107 · Cited by 17
Xu, M., Xia, Z.-Y., Sun, J., Liu, C., An, Y., Xu, J., Zhang, S.-H., Zhong, X., Zeng, N., Ma, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1395047 · Cited by 16
Yu, Z. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i13.1979 · Cited by 16
Aberrant maspin expression in human endometrial cancer
Murai, S., Maesawa, C., Masuda, T., & Sugiyama, T. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00266.x · Cited by 16
Role of Senescence in Tumorigenesis and Anticancer Therapy
Stoczyńska-Fidelus, E., Węgierska, M., Kierasińska, A., Ciunowicz, D., & Rieske, P. (2022) · Journal of Oncology · doi:10.1155/2022/5969536 · Cited by 15
Melounková, L., Machálková, A., Havelek, R., Honzíček, J., Řezáčová, M., Císařová, I., Peterová, E., & Vinklárek, J. (2019) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2019.03.015 · Cited by 15
Cheng, H., Chang, S.-M., Cheng, Y., Liu, H., & Chen, Y.-C. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9191-x · Cited by 15
Cellular Senescence Exacerbates Features of Aging in the Eyes
Kitazawa, K., Campisi, J., Numa, K., Patel, S. K., King, C. D., Matsumoto, A., Sotozono, C., Desprez, P., & Schilling, B. (2023) · doi:10.59368/agingbio.20230014 · Cited by 14
Al‐Halabi, R., Merhi, R. A., Chakilam, S., El‐Baba, C., Hamade, E., Fazio, P. D., Ocker, M., Schneider‐Stock, R., & Gali‐Muhtasib, H. U. (2014) · Molecular Carcinogenesis · doi:10.1002/mc.22172 · Cited by 14
The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells
Fourie, C., Davis, T., Kriel, J., & Engelbrecht, A. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.05.020 · Cited by 13
Deinhardt‐Emmer, S., Deshpande, S., Kitazawa, K., Herman, A. B., Bons, J., Rose, J., Kumar, P. A., Anerillas, C., Neri, F., Ciotlos, S., et al. (2023) · Aging and Disease · doi:10.14336/ad.2023.0812 · Cited by 13
Senescence and Cell Cycle Control
Kiyokawa, H. (2006) · Springer eBooks · doi:10.1007/400_001 · Cited by 14
Characterization of ATF3 Induction after Ionizing Radiation in Human Skin Cells
Koike, M., Ninomiya, Y., & Koike, A. (2005) · Journal of Radiation Research · doi:10.1269/jrr.46.379 · Cited by 12
Brahim, S., Abid, K., & Kénani, A. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2007.08.032 · Cited by 12
Abdelmoaty, A. A. A., Chen, J., Zhang, K., Wu, C., Li, Y., Li, P., & Xu, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1422363 · Cited by 11
Peng, X., Liu, N., Zeng, B., Bai, Y., Xu, Y., Chen, Y., Chen, L., & Xia, L. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1450626 · Cited by 11
Thill, M., Berna, M. J., Kunst, F., Wege, H., Strunnikova, N. V., Gordiyenko, N., Grierson, R., Richard, G. W., & Csaky, K. G. (2011) · PubMed Central · Cited by 11
Exploiting Drug-Induced Senescence in Transgenic Mouse Models
Kılıç, M., & Schmitt, C. A. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-17 · Cited by 9
Gupta, K. P., Dholaniya, P. S., Chekuri, A., & Kondapi, A. K. (2015) · AGE · doi:10.1007/s11357-015-9789-6 · Cited by 9
A Novel Role for Thyroid Hormone Receptor Beta in Cellular Radiosensitivity
Matsuse, M., Saenko, V., Sedliarou, I., Rogounovitch, T., Nakazawa, Y., Mitsutake, N., Akulevich, N. M., Namba, H., & Yamashita, S. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07065 · Cited by 9
Marcadores de senescencia celular en cáncer y precáncer oral
Campo, J., Cano‐Sánchez, J., López-Durán, M., Palacios-Sánchez, B., Sánchez-Gutiérrez, J., & Martínez, A. B. (2008) · Avances en Odontoestomatología · doi:10.4321/s0213-12852008000100007 · Cited by 8
Nucleophagy removes cytotoxic trapped PARP1
Hoslett, G., Tribble, S., Lascaux, P., Koukouravas, S., Torrecilla, I., Song, W., Hou, C. X., Li, X., Fernández, M. G., Gregoriis, G. D., et al. (2026) · Nature Cell Biology · doi:10.1038/s41556-026-01961-5 · Cited by 8
Hu, Y., Lau, P., Baumstark‐Khan, C., Hellweg, C. E., & Reitz, G. (2012) · Advances in Space Research · doi:10.1016/j.asr.2012.02.001 · Cited by 8
Guichard, S. M., Hua, M. L., Kang, P., Macpherson, J. S., & Jodrell, D. I. (2007) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0408-1 · Cited by 8
Choi, O. R., & Lim, I. K. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.03.038 · Cited by 7
Porcelli, G., D’Accardo, C., Angeloro, F., Cucchiara, M., Bianca, P., Pantina, V. D., Roozafzay, N., Modica, C., Gaggianesi, M., Bella, S. D., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02499-0 · Cited by 7
P53-dependent induction of serine proteases in irradiated mouse colon
Lin, S., Cook, M., Finnberg, N. K., Bernhard, E. J., Baldwin, D. A., & El‐Deiry, W. S. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.12.1448 · Cited by 7
Kim, K.-H., Park, B., Rhee, D., & Pyo, S. (2018) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00323 · Cited by 6
Sarogni, P., Brindani, N., Zamborlin, A., Gonnelli, A., Menicagli, M., Mapanao, A. K., Munafò, F., Vivo, M. D., & Voliani, V. (2024) · Scientific Reports · doi:10.1038/s41598-024-59592-5 · Cited by 6
Lu, H. F., Tsou, M., Lin, J. G., Ho, C. C., Liu, J. Y., Chuang, J., & Chung, J. (2005) · PubMed · Cited by 6
Unraveling senescence in cancer: mechanistic complexities and therapeutic opportunities
Tiwari, P., Shukla, S. K., & Verma, S. R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10630-z · Cited by 5
Comprehensive Cellular Senescence Evaluation to Aid Targeted Therapies
Zhou, X., Zhu, X., Wang, W., Wang, J., Wen, H., Zhao, Y., Zhang, J., Xu, Q., Zhao, Z., & Ni, T. (2025) · Research · doi:10.34133/research.0576 · Cited by 5
Hori, M., Suzuki, K., Udono, M. U., Yamauchi, M., Mine, M., Watanabe, M., Kondô, S., & Hozumi, Y. (2008) · Archives of Dermatological Research · doi:10.1007/s00403-008-0915-5 · Cited by 5
Gupta, K. P., Dholaniya, P. S., Chekuri, A., & Kondapi, A. K. (2015) · AGE · doi:10.1007/s11357-015-9810-0 · Cited by 4
Midkine and Chemoresistance in Cancers
Takei, Y., & Kadomatsu, K. (2012) · Springer eBooks · doi:10.1007/978-94-007-4234-5_20 · Cited by 3
Using a 3-d model system to screen for drugs effective on solid tumors
Fayad, W. (2011) · Figshare · Cited by 2
Distinct Roles of the Pocket Proteins in the Control of Cell Cycle
Vogiatzi, P., & Claudio, P. P. (2009) · Springer eBooks · doi:10.1007/978-3-642-02112-1_19 · Cited by 2
Targeting Inducible Chemotherapy Resistance Mechanisms in Colon Cancer
Ljungman, D., & Cusack, J. C. (2007) · Humana Press eBooks · doi:10.1385/1-59259-893-5:209 · Cited by 2
Biological Impact of Senescence Induction in Prostate Cancer
Jarrard, D. F. (2010) · Defense Technical Information Center (DTIC) · doi:10.21236/ada551887 · Cited by 1
Senescence Induced by Repression of Human Papillomavirus Oncogenes in Cervical Cancer Cells
DiMaio, D., Johung, K. L., Goodwin, E. C., Horner, S. M., & Yates, K. E. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-14 · Cited by 1
Gene Program Signatures for Papillomavirus E2-Mediated Senescence in Cervical Cancer Cells
Williams, S. S., Aronow, B. J., & Wells, S. I. (2007) · Humana Press eBooks · doi:10.1385/1-59259-893-5:69 · Cited by 1
Analysis of senescence-like growth arrest induced by RUNX1 and its fusion derived oncoproteins
Wolyniec, K. (2008) · Enlighten: Theses (The University of Glasgow) · doi:10.5525/gla.thesis.578 · Cited by 1
Maria, V. C., & Artenie, V. (2007) · Analele Stiintifice ale Universitatii "Alexandru Ioan Cuza" din Iasi Sec. II a. Genetica si Biologie Moleculara · Cited by 1
Impact of aging in bacterial endophthalmitis
Maiti, S., Naik, P., Pandey, S., & Joseph, J. (2025) · Expert Review of Ophthalmology · doi:10.1080/17469899.2025.2550707 · Cited by 1
Cellular Senescence and Its Effects on Carcinogenesis
Campisi, J. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-12 · Cited by 1
Ángel, K. S. O. D. (2019) · doi:10.24275/uami.12579s30p · Cited by 1
Chiu, Y., Ishida, R., Moriyama, Y., Grašič, J., & Kono, K. (2025) · RNA Biology · doi:10.1080/15476286.2025.2551299 · Cited by 1
Treatment-Induced Tumor Cell Senescence and Its Consequences
Broude, E. V. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-15 · Cited by 1
Self-citationRole of Molecular Chaperones in Cell Senescence
Sherman, M. Y., & Yaglom, J. A. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6401-2_8 · Cited by 1
Angiotensin II induced premature senescence of human vascular smooth muscle cells
Mistry, Y. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique) · Cited by 1
Whole-Genome Analysis of Cancer
Enkemann, S. A., McLoughlin, J. M., Jensen, E. H., & Yeatman, T. J. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-576-3_3 · Cited by 1
An Overview of Mechanistic Toxicogenomic Studies
Scheel, J., von Brevern, M., & Storck, T. (2003) · CRC Press eBooks · doi:10.1201/9780203504819.ch10 · Cited by 1
El‐Far, A. H., Noreldin, A. E., Jaouni, S. K. A., & Mousa, S. A. (2020) · Research Square · doi:10.21203/rs.3.rs-52516/v1 · Cited by 1
Drullion, C. (2011) · theses.fr (ABES) · doi:10.70675/8163e0e5z6a58z4c23zbaa4z16554309abe8 · Cited by 1
Étude du mécanisme de régulation de la sénescence et de p53 par la protéine SOCS1
Calabrese, V. (2012) · doi:10.71781/28688 · Cited by 1
Entwicklung eines transkriptionell regulierten Systems zur konditionalen Immortalisierung
May, T. (2005) · Digitale Bibliothek Braunschweig (Verbundzentrale Göttingen (VZG)) · doi:10.24355/dbbs.084-200511080100-339 · Cited by 1
Kholghi, A. O. A. (2014) · Figshare · Cited by 1
Correlación clínico patológica de la ruta de transducción TNF/IL-1/NF-KB en cáncer de próstata
Alcaide, C., & Ramón, J. (2012) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
The impact of MAO-A in cellular senescence
Sequeiros, P. E. D. M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Mechanisms and treatment strategies to overcome resistance to non-cytotoxic therapy in cancer
Kuljaca, S. (2010) · UNSWorks (University of New South Wales, Sydney, Australia) · doi:10.26190/unsworks/22911 · Cited by 1
Mechanisms of chemoresistance in breast cancer and liposarcoma.
LaPensee, E. W. (2008) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
The Role of Prolactin in the Cellular Response to DNA Damaging Agents
Atıcı, Ö. K. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/28347 · Cited by 1
Bode, A. M. (2002) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(02)00585-4 · Cited by 1
Die Rolle der Metalloprotease ADAM17 während der zellulären Seneszenz
Effenberger, T. (2014) · MACAU: Open Access Repository of Kiel University (University Library Kiel)
A proteomic approach for understanding the metabolic adaptations in non-small cell lung cancer
Martín-Bernabé, A. (2018) · theses.fr (ABES) · doi:10.70675/426e7b40z057az4326z8cfez7da3a5c12c7e
Küçükgüven, A., & Vargel, İ. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98804-9.00003-7
Senescence Regulation in Cancer Therapy
Rebbaa, A. (2008) · CRC Press eBooks · doi:10.3109/9781420020502-16
Induction of cellular senescence as a novel therapeutic strategy for melanoma treatment
Zhang, G. (2012) · ScholarlyCommons (University of Pennsylvania)
TRANSCRIPTOME STUDIES OF CELL-FATE AND AGING
Larsson, O. S. (2005) · Figshare
Participación de p19INK4d en la inducción de senescencia genotóxica y replicativa
Sonzogni, S. V. (2012) · Repositorio Digital Institucional de la Universidad de Buenos Aires (Universidad de Buenos Aires)
Regulation and Repair of Neural Stem Cells and the Neurogenic Niche
Fatt, M. P. (2017) · TSpace (University of Toronto)
Benkdane, M. (2012) · theses.fr (ABES) · doi:10.70675/45d1370fz6819z4b07zb446zd155483ab1de
Metadata
- Authors
- Chang, B.-D., Swift, M. E., Shen, M., Fang, J., Broude, E. V., & Roninson, I. B.
- Affiliations
- University of Illinois Chicago (US)
- Corresponding author
- Roninson, Igor B.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2001-12-18
- Volume
- 99
- Issue
- 1
- Pages
- 389-394
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC117570
- OpenAlex
- W2162118018
- Cited by
- 312
- References
- 39
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 10 · 2023: 11 · 2022: 10 · 2021: 10 · 2020: 12 · 2019: 9 · 2018: 12 · 2017: 6 · 2016: 8 · 2015: 10 · 2014: 6 · 2013: 13 · 2012: 16
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r37ca040333-15)
- National Cancer Institute (R37 CA 40333, R01CA089636, R01CA062099)
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK0773909)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- drug-induced senescence, doxorubicin, colon cancer cells, p53, tumor suppressor, growth inhibitors, anti-apoptotic factors, angiogenic factors, chemoresistance, gene expression profiling
- MeSH terms
- Animals, Antineoplastic Agents, Cell Division, Doxorubicin, Humans, Neoplasms, Phenotype, RNA, Messenger, Time Factors, Tumor Cells, Cultured, Down-Regulation, Up-Regulation, Genes, p53, Proto-Oncogene Proteins p21(ras), Cellular Senescence, DNA, Complementary, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.